DLMDA pre-amplification preserves genome-wide copy-number profiles in FFPE samples despite reduced detection sensitivity
Methods · 2026-12 · 256 · 160-169
DOI: 10.1016/j.ymeth.2026.10.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Methods, 2026-12. Verfasst von C Guerrero Quiles und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health and Manchester Cancer Research Centre, The Universit…. Hauptthemen laut MEDLINE: DNA Copy Number Variations, Nucleic Acid Amplification Techniques, Prostatic Neoplasms, Whole Genome Sequencing. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Manchester Biomedical Research Centre, Prostate Cancer UK, Cancer Research UK Manchester Centre.
Abstract (Originalsprache)
Whole-genome sequencing (WGS) enables comprehensive analysis of tumour genomes, but its use in formalin-fixed paraffin-embedded (FFPE) samples is limited by DNA fragmentation and low yields. Whole-genome amplification (WGA) methods such as multiple displacement amplification (MDA) can boost DNA availability but distort copy-number alteration (CNA) profiles. DNA ligation-mediated MDA (DLMDA) mitigates this bias by reconstituting fragmented templates, yet its performance in FFPE-derived DNA remains uncertain. We compared paired DLMDA pre-amplified (2 h, 8 h) and non-pre-amplified FFPE prostate tumour samples from 15 archival blocks (5, 15 and 20 years old). DLMDA increased DNA yield by 7.3-15.4-fold, with global CNA patterns largely preserved. However, DLMDA significantly reduced the detected total CNA burden from 10.4 % (baseline) to 4.6 % after 2 h and 7.6 % after 8 h pre-amplification, independently of FFPE sample age. CNA dropouts were randomly distributed across the genome, indicating that DLMDA does not introduce regional bias. Our results show that DLMDA enables robust DNA yield recovery and avoids false-positive CNA artefacts, suggesting DLMDA can be used as rescue strategy for poor quality, low yield, FFPE-derived DNA, but at the cost of reduced CNA sensitivity. While suitable for CNA screening pipelines through WGS, further improvements are required to minimise the false-negative risk and improve the technique's sensitivity for FFPE-based genomics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health and Manchester Cancer Research Centre, The University of Manchester, Oglesby Cancer Research Centre, Manchester, M20 4GJ,…
- Cancer Research UK Manchester Institute, Manchester, M20 4BX, UK.
Förderung
- Manchester Biomedical Research Centre
- Prostate Cancer UK
- Cancer Research UK Manchester Centre
Zitieren
APA
Guerrero Quiles, C., Lodhi, T., Sellers, R., Sahoo, S., Weightman, J., Breitwieser, W., Sanchez-Martinez, D., Bartak, M., Shamim, A., Lyons, S., Reeves, K. J., Reed, R., Hoskin, P., West, C. M., Forker, L. J., Smith, T. A. D., Bristow, R. G., Wedge, D. C., Choudhury, A., & Biolatti, L. V. (2026). DLMDA pre-amplification preserves genome-wide copy-number profiles in FFPE samples despite reduced detection sensitivity. Methods, 256, 160-169. https://doi.org/10.1016/j.ymeth.2026.10.002
Vancouver
Guerrero Quiles C, Lodhi T, Sellers R, Sahoo S, Weightman J, Breitwieser W, et al. DLMDA pre-amplification preserves genome-wide copy-number profiles in FFPE samples despite reduced detection sensitivity. Methods. 2026;256:160-169. doi:10.1016/j.ymeth.2026.10.002
BibTeX
@article{GuerreroQuiles2026,
author = {Guerrero Quiles, C and Lodhi, T and Sellers, R and Sahoo, S and Weightman, J and Breitwieser, W and Sanchez-Martinez, D and Bartak, M and Shamim, A and Lyons, S and Reeves, K J and Reed, R and Hoskin, P and West, C M and Forker, L J and Smith, T A D and Bristow, R G and Wedge, D C and Choudhury, A and Biolatti, L V},
title = {DLMDA pre-amplification preserves genome-wide copy-number profiles in FFPE samples despite reduced detection sensitivity},
journal = {Methods},
year = {2026},
volume = {256},
pages = {160--169},
doi = {10.1016/j.ymeth.2026.10.002}
}
EUVIMED